Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
International Journal of Radiation Oncology, Biology, Physics|March 31, 2004
Retrospective analysis of results of p(65)+Be neutron therapy for treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Leuve. Part II: Side effects and their influence on quality of life measured with QLQ-C30 of EORTCPierre G M Scalliet, Vincent Remouchamps, Desmond Curran, et al.European Journal of Anaesthesiology|September 28, 2011
Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer?Patrice Forget, Bertrand Tombal, Jean-Louis Scholtès, et al.European Journal of Cancer (Oxford, England : 1990)|October 15, 2005
Patients at high risk of progression after radical prostatectomy: do they all benefit from immediate post-operative irradiation? (EORTC trial 22911)Laurence Collette, Hein van Poppel, Michel Bolla, et al.Virchows Archiv : an International Journal of Pathology|August 31, 2006
Impact of pathology review of stage and margin status of radical prostatectomy specimens (EORTC trial 22911)Theodorus H van der Kwast, Laurence Collette, Hein Van Poppel, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2007
Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911Theodorus H Van der Kwast, Michel Bolla, Hein Van Poppel, et al.Lancet (London, England)|August 16, 2005
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)Michel Bolla, Hein van Poppel, Laurence Collette, et al.European Urology|February 4, 2014
Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional studySteven Joniau, Alberto Briganti, Paolo Gontero, et al.European Urology|April 2, 2014
Pretreatment tables predicting pathologic stage of locally advanced prostate cancerSteven Joniau, Martin Spahn, Alberto Briganti, et al.Advances in Urology|March 9, 2012
The role of adjuvant hormonal treatment after surgery for localized high-risk prostate cancer: results of a matched multiinstitutional analysisMaria Schubert, Steven Joniau, Paolo Gontero, et al.Pageof 1